Quick Answer
Clearside Biomedical, Inc. reported Operating Income of -$28.88 million for fiscal year 2024.
Clearside Biomedical, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2024 | -$28.88M | -16.3% |
| 2023 | -$24.84M | +17.9% |
| 2022 | -$30.28M | -4728.9% |
| 2021 | -$627.0K | +96.5% |
| 2020 | -$17.93M | +40.8% |
| 2019 | -$30.30M | +63.5% |
| 2018 | -$82.94M | -42.0% |
| 2017 | -$58.41M | -131.8% |
| 2016 | -$25.20M | -45.5% |
| 2015 | -$17.32M | -76.3% |
| 2014 | -$9.82M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$7.04M | -18.6% | -97.3% |
| June 30, 2025 | -$3.57M | +53.0% | +31.5% |
| March 31, 2025 | -$5.21M | +36.6% | +12.3% |
| September 30, 2024 | -$5.93M | +15.9% | +21.8% |
| June 30, 2024 | -$7.59M | -4.4% | +7.5% |
| March 31, 2024 | -$8.21M | -7.9% | -16.4% |
| September 30, 2023 | -$7.05M | -4.9% | +3.0% |
| June 30, 2023 | -$7.27M | +7.2% | +4.4% |
- Clearside Biomedical, Inc. showed a decrease of -16.3% in Operating Income compared to the prior fiscal year.
- Over the 2014–2024 period, Clearside Biomedical, Inc.’s operating income has declined by 194.0% (from -$9.82 million to -$28.88 million).
- The most recent figure is from Clearside Biomedical, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 27, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: